Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 96, Issue 1, Pages 10-13Publisher
B M J PUBLISHING GROUP
DOI: 10.1136/bjophthalmol-2011-300183
Keywords
-
Categories
Ask authors/readers for more resources
Chronic central serous retinopathy (CSR) is characterised by frequent exacerbations and a poor visual prognosis. Very few therapies exist for chronic CSR, and the existing therapies are often ineffective. Thus, novel therapies to combat this frustrating disorder are needed. Presented here is a case detailing a patient with chronic CSR with persistent subfoveal fluid of 2 years' duration that completely resolved with 1 month of oral rifampin therapy. As a cytochrome P450, 3A4 inducer, rifampin is thought to favourably alter the metabolism of endogenous steroids, thereby leading to an improvement in CSR manifestations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available